Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar;3(3):38.
doi: 10.3978/j.issn.2305-5839.2015.01.19.

Rate of early onset Alzheimer's disease: a systematic review and meta-analysis

Xi-Chen Zhu  1 , Lan Tan  1 , Hui-Fu Wang  1 , Teng Jiang  1 , Lei Cao  1 , Chong Wang  1 , Jun Wang  1 , Chen-Chen Tan  1 , Xiang-Fei Meng  1 , Jin-Tai Yu  1
Affiliations

Rate of early onset Alzheimer's disease: a systematic review and meta-analysis

Xi-Chen Zhu et al. Ann Transl Med. 2015 Mar.

Erratum in

Abstract

It is generally accepted that the population rate of early onset Alzheimer's disease (EOAD) in Alzheimer's disease (AD) is 1-2%. However, the true population based rate of EOAD has never been verified by a systematic review and meta-analysis. We used electronic searches of Cochrane Library, Embase, Medline and PubMed databases to identify published related studies. The systematic review and meta-analysis was then to be conducted to calculate a pooled rate of EOAD and make comparisons between studies and geographic distribution. A total of 13 papers were included in our systematic review and meta-analysis. The rate of EOAD, 5.5% [95% confidence interval (CI): 0.039-0.079, P<0.001], was generated after pooled analysis of all studies in random effect model. The pooled analysis of the rate in developed country was 5.9% (95% CI: 0.040-0.085, P<0.001). The pooled analysis of the rate in developing countries was 4.4% (95% CI: 0.028-0.066, P<0.001). Our study showed that the rate of EOAD in AD is 5.5%, not 1-2% as usually demonstrated. And our results indicated that the rate in developed countries was relative higher than in developing countries. Further trials with larger samples across more countries and more careful designed of experiments are required to confirm whether our findings are truly significant.

Keywords: Alzheimer’s disease (AD); Early onset Alzheimer’s disease (EOAD); meta-analysis; rate.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of study identification process.
Figure 2
Figure 2
Forest plots show population based studies included in pooled analysis.
Figure 3
Figure 3
Forest plots show the pooled analysis of included studies across different countries.
Figure S1
Figure S1
Funnel plots of population based studies included in pooled analysis.
See this image and copyright information in PMC

References

    1. Rossor MN, Fox NC, Mummery CJ, et al. The diagnosis of young-onset dementia. Lancet Neurol 2010;9:793-806. - PMC - PubMed
    1. Jiang T, Yu JT, Tan L. Novel disease-modifying therapies for Alzheimer's disease. J Alzheimers Dis 2012;31:475-92. - PubMed
    1. Smits LL, Pijnenburg YA, Koedam EL, et al. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile. J Alzheimers Dis 2012;30:101-8. - PubMed
    1. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med 2010;362:329-44. - PubMed
    1. Jiang T, Yu JT, Tian Y, et al. Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors. Curr Alzheimer Res 2013;10:852-67. - PubMed